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proinflammatory M1 phenotype impaired the survival of oligodendrocytes and the differentiation/maturation of oligodendrocyte precursor cells (OPCs). 6, 7 Elevated levels of glucose in culture media influence monocyte/macrophage responses and shift their polarization toward a M1-like inflammatory phenotype. 8 However, it is not known whether hyperglycemia during and after stroke, as experienced in T2DM, modifies microglia/ macrophage polarization and if the resulting polarization state influences WM injury and functional deficits.
In the current study, we assessed poststroke WM integrity and microglia/macrophage polarization in the db/db homozygous mouse model of T2DM, db/+ heterozygous mice, and wild-type (WT) mice at various time points after permanent distal middle cerebral artery occlusion (dMCAO). We observed that T2DM exacerbated WM damage and led to prolonged functional deficits after stroke. The presence of a high glucose environment promoted a proinflammatory phenotypic shift in microglia/macrophages, and this proinflammatory shift impaired oligodendrogenesis and WM repair.
Materials and Methods
The data that support the findings of this study are available from the corresponding author on request.
Animal Model
All animal experiments were approved by the University of Pittsburgh Institutional Animal Care and Use Committee and performed in accordance with the principles outlined in the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Male C57/BL6 mice, db/+ mice (Lepr db /+), and db/db mice (Lepr db/db ; 10 weeks old) were purchased from the Jackson Laboratory (Bar Harbor, ME). Mice were randomly divided into the sham surgery or ischemic injury group using a lottery drawing box. Mice in the latter group were subjected to dMCAO, as described previously. 5 Cerebral blood flow (CBF) was measured using the 2-dimensional laser speckle imaging system and laser Doppler flowmetry. Mice with <70% reduction of blood flow in the ischemic core or that died during surgery were excluded from further analyses. Mice in the sham surgery group were similarly anesthetized and operated on but not subjected to MCA cauterization. All efforts were made to minimize animal suffering. All outcome end points were measured by investigators blinded to experimental group assignments. A total of 243 mice (29 shamoperated and 197 ischemic mice) were used, including 17 mice that were excluded from further assessments because of death after ischemia. The mortality rate was 0% in WT mice (0 of 66), 0% in db/+ mice (0 of 67), and 22.97% in db/db mice (17 of 74).
Primary Microglia and OPC Cultures
Primary microglia and OPCs were prepared from the whole brains of 1-day-old Sprague-Dawley rat pups, as previously described. 6 Microglia were cultured for 48 hours in media with a normal concentration of glucose (5.5 mmol/L) or high glucose (15 mmol/L), in the presence or absence of low concentrations of lipopolysaccharides (LPS; 2.5 ng/mL). For coculture experiments, pretreated microglia were cocultured with OPCs for 3 days.
Statistical Analyses
All data are presented as mean±SEM. Differences between groups were compared using the Student t test (for single comparison) or 1-way ANOVA for continuous variables with normal distributions. Differences in means across groups with repeated measurements over time were analyzed using repeated measures ANOVAs. When the ANOVA revealed significant differences, the post hoc Bonferroni test was used for pairwise comparisons between means. Linear correlation analyses were performed using Pearson product-moment correlation analyses. Statistical differences were deemed significant when P≤0.05. Full descriptions of experimental procedures are available in the in the online-only Data Supplement.
Results

Diabetic and Nondiabetic Mice Exhibit Similar rCBF After Ischemic Injury
In all groups, regional CBF (rCBF) in the left MCA territories decreased slightly after left common carotid artery ligation and significantly dropped after occlusion of the left MCA ( Figure IA and IB in the online-only Data Supplement). Thereafter, rCBF recovered gradually and returned to ≈80% of baseline values at 7 days after dMCAO. There was no significant difference in rCBF between WT, db/+, and db/db groups at any time points measured. Further analyses revealed no difference among 3 groups in the cortical areas where the rCBF decreased to <30% or between 30% and 50% of baseline values ( Figure IC in the online-only Data Supplement). Physiological parameters, including blood pH, blood gases, and concentrations of electrolytes, were comparable between WT, db/+, and db/db groups before and after surgery (Table I in the online-only Data Supplement).
Diabetic Mice Exhibit Worse Sensorimotor Performance Compared With Nondiabetic Mice After dMCAO
The poststroke mortality rate ( Figure 1A ) and blood sugar levels ( Figure 1B ) of db/db mice were significantly higher than WT and db/+ mice. The increased body weight in sham db/db mice (WT: 24.74±2.349 g, db/+: 27.9±1.769 g, db/db: 45.41±2.681 g; WT versus db/db, P<0.0001; db/+ versus db/ db, P<0.0001; 1-way ANOVA followed by Bonferroni post hoc) appeared to impair their performance in multiple behavior tests, including the rotarod and footfault tests (data not shown). The adhesive removal test, which is not affected by differences in body weight, was therefore used to assess poststroke sensorimotor function ( Figure 1C In the open field test, the db/db mice were significantly less active than WT and db/+ mice and traveled shorter total distances in the arena (Figure 1Da ). These data suggest a reduction in overall exploratory/locomotor activity in diabetic mice under sham injury conditions. Interestingly, locomotor activity exhibited a significant gene dosage effect in that db/+ mice traveled shorter distances compared with WT mice but longer distances than db/db mice. After stroke, the total distance traveled decreased in both WT and db/+ groups and remained at low levels in db/db mice compared with the other 2 groups (Figure 1Dc) . As a result, the reduction in locomotor activity was more dramatic in WT and db/+ stroke groups versus diabetic stroke mice because of the low basal activity levels in the latter. In addition, the db/db and db/+ mice spent much less time exploring the central area of the open field than WT mice after either sham operation (Figure 1Db ) or ischemic stroke (Figure 1Dd ), suggesting anxiety-like behavior in diabetic animals.
The Morris water maze was used to assess long-term cognitive function after dMCAO ( Figure II in the onlineonly Data Supplement). The swimming speed of db/db mice was much slower than WT and db/+ mice after either sham operation or dMCAO, probably because of the increased body weight in db/db mice. Spatial learning capacity was, therefore, quantified using path efficiency, calculated as the Euclidean distance between the starting location and the final location divided by the total distance traveled, 9 to adjust for differences in swimming speed. The WT mice, db/+ mice, and db/db mice demonstrated comparable path efficiency after sham operation and dMCAO ( Figure II 
Diabetic Mice Exhibit Greater Neuronal Tissue Loss Compared With Nondiabetic Mice After Ischemic Injury
Neuronal tissue loss was measured by neuronal nuclei (NeuN) immunostaining at 3 and 35 days after dMCAO. Infarct volume was normalized to the contralateral hemisphere. The db/db mice demonstrated significantly enlarged areas of neuronal tissue loss at 3 days after stroke (Figure 2A ). Although neuronal tissue loss was larger in db/db mice than the other 2 lines at 35 days after dMCAO, the effect did not reach statistical significance ( Figure 2B , WT versus db/db, P=0.08; db/+ versus db/db, P=0.06). Correlation analyses revealed a weak but statistically significant correlation between neuronal tissue loss at 35 days poststroke and behavioral performance in the adhesive removal test from days 14 to 35 poststroke ( Figure 2C ). The db/db mice exhibit impaired sensorimotor performance but similar cognitive functions compared with db/+ mice and wild-type (WT) mice up to 35 d after distal middle cerebral artery occlusion (dMCAO). A, Poststroke mortality rates were higher in db/db mice than WT and db/+ mice. Note that the data points for the db/+ mice (blue triangles) overlap those of the WT mice (black circles). Log-rank test. n=12-13/group. B, The blood sugar levels of db/ db mice were significantly higher than WT and db/+ mice. n=8/group. C, Sensorimotor functions were evaluated by the adhesive removal test. The latencies to contact and remove the tape were recorded. n=6/sham group. n=8-12/dMCAO group. D, In the open field test, total distances traveled in the arena and the time spent in the central area of the open field were recorded. n=4/sham group. n=8-12/dMCAO group. *P<0.05, **P<0.01, ***P<0.001, WT vs db/db; +P<0.05, ++P<0.01, +++P<0.001, WT vs db/+; #P<0.05, ##P<0.01, ###P<0.001, db/+ vs db/db; 2-way repeated measures ANOVA followed by the Bonferroni post hoc. Both main effects and pairwise comparisons (with corrections) are displayed.
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Deterioration of WM Integrity After Ischemic Injury in Diabetic Mice Is Associated With Impairments in Long-Term Neurological Functions
Axons and myelin were immunostained with NF200 and MBP (myelin basic protein), respectively, to evaluate differences in WM integrity in WT mice, db/+ mice, and db/db mice. Although db/db mice showed no significant differences in MBP loss early (3 days) after stroke, greater loss of MBP immunostaining in the external capsule (EC) was observed in db/db mice compared with WT mice and db/+ mice 35 days after dMCAO ( Figure III in the online-only Data Supplement). The WT mice and db/+ mice demonstrated proportional loss in NF200 and MBP levels as a percentage of their respective contralateral levels in the EC and cortex after dMCAO, rendering a NF200/MBP ratio of ≈1.0 for both groups ( Figure 3B ). The ratio of NF200/MBP was comparable in the EC and the cortex of WT mice, db/+ mice, and db/db mice at 3 days after dMCAO. In contrast, the ratio of NF200/MBP was significantly higher in the EC of db/db mice at 14 and 35 days after dMCAO ( Figure 3A and 3B), suggesting greater loss of myelin (MBP staining) than axons (NF200 staining) compared with WT mice and db/+ mice. These data reveal greater demyelination in diabetic mice after dMCAO. A negative correlation was observed between MBP staining intensity and the latency to contact and remove the tape in the adhesive removal test, suggesting a robust association between WM integrity and sensorimotor function ( Figure 3C ). Electrophysiological studies showed that the db/db mice exhibited similar reduction in compound action potential amplitudes in myelinated N1 fibers and unmyelinated N2 fibers in the EC, compared with db/+ and WT mice at 3 days after stroke (Figure 3Db ), indicating comparable initial white mater injury among the 3 mouse lines. However, diabetic mice exhibited lower amplitudes in myelinated N1 fibers and unmyelinated N2 fibers in the EC when the stimulation strength exceeded 750 μA at 35 days after stroke (Figure 3Dc ). Sham-injured WT mice, db/+ mice, and db/db mice showed no difference in N1 or N2 compound action potential amplitude (Figure 3Da ). No difference was observed in compound action potential N1 velocity between diabetic and nondiabetic mice ( Figure 3D ).
Poststroke Oligodendrogenesis Is Inhibited in Diabetic Mice
Bromodeoxyuridine (BrdU) was injected at 3 to 6 days after dMCAO to label newly generated cells. The total number of BrdU + cells in the EC and cortex was decreased in db/db mice compared with nondiabetics at 14 and 35 days after stroke ( Figure 
Diabetic Mice Exhibit Enhanced Inflammatory Microglia/Macrophage Responses
The numbers of CD206 +
Iba1
+ M2-like microglia/macrophages were significantly reduced ( Figure 5A ), whereas the numbers of CD16 +
+ M1-like microglia/macrophages were significantly increased ( Figure 5A ) in the EC of db/db mice compared with WT and db/+ mice at 3 and 14 days after stroke. Similar changes in the microglia/macrophage phenotypes Consistent with the shift of microglia/macrophage phenotype toward a proinflammatory modality in diabetic mice, the production of inflammatory cytokines (interleukin-1β and interleukin-6) was significantly elevated in the db/db mice compared with WT or db/+ mice at 14 days after stroke ( Figure 5C ).
Exposure to High Glucose Levels Shifts Microglial Polarization Toward the Proinflammatory State and Impairs OPC Differentiation Under Both Physiological and Inflammatory Conditions
Primary cultures were used to assess the effects of high glucose levels on microglial phenotypic changes and the subsequent impact on OPC differentiation ( Figure 6A ). Microglia were cultured in media for 48 hours with a standard concentration of glucose (5.5 mmol/L) or high glucose (15 mmol/L-analogous to a diabetic condition within the cell culture system). Exposure to high glucose slightly increased expression of the M1 marker CD16 ( Figure 6B ). When microglia were exposed to a low concentration of LPS, the high glucose levels shifted microglia toward the M1 polarity, increasing the expression of 3 M1 markers (CD16, inducible nitric oxide synthase, and tumor necrosis factor α) and inhibiting the expression of 2 M2 markers (CD206 and transforming growth factor β; Figure 6B ). Coculture of the unstimulated microglia in standard glucose concentrations increased OPC differentiation, as revealed by increased mRNA expression of maturation markers mbp, mog, and plp compared with OPC cultures without microglia (dashed lines in Figure 6C ). Cocultures of either normal or LPSstimulated microglia in high glucose with OPCs significantly inhibited mRNA expression of mbp, mog, and plp in the OPCs (Figure 6C ). High glucose alone had no direct effect on OPC differentiation (data not shown). These results suggest that high glucose-treated microglia inhibit OPC differentiation either under physiological or inflammatory conditions. Immunofluorescent staining confirmed decreases in the percentages of MBP + oligodendrocytes when cocultured with microglia under high glucose conditions, either in the absence or presence of LPS ( Figure 6D ).
Discussion
This study is the first to demonstrate that the condition of T2DM exacerbates long-term functional deficits after stroke, coincident with greater disruption in the structural and functional integrity of WM. Indeed, long-term functional deficits after ischemic stroke in T2DM mice (db/db) correlated with greater loss of MBP + WM, as well as NeuN + gray matter compared with nondiabetic stroke mice (WT and db/+). However, sensorimotor dysfunction was more strongly correlated with loss of WM than parallel loss of gray matter. Consistent with these findings, clinical magnetic resonance imaging studies also report a positive association between the deterioration in WM structure in patients with stroke and poor neurological outcomes and prognosis. 4, 10 Interestingly, the db/db mice exhibited similar loss of MBP and reductions in fiber tract conduction properties compared with db/+ and WT mice early after stroke, indicating comparable initial white mater injury among the 3 mouse lines. Therefore, the deterioration in WM integrity in diabetic mice 35 days after stroke might be better associated with impaired recovery rather than with greater initial injury.
Previous animal studies have suggested several mechanisms that may underlie the deterioration of WM after brain ischemia in diabetic mice. 11, 12 One potential mechanism is impairment in the proliferation and survival of OPCs in WM, as shown in diabetic mice after bilateral common carotid artery stenosis. 11 We demonstrated here that the deterioration of WM integrity in diabetic mice is accompanied by reduced numbers of proliferating OPCs and fewer newly generated mature oligodendrocytes. These results suggest that diabetes mellitus has a profound negative impact on OPC differentiation and maturation after stroke. Although db/db mice exhibited impaired oligodendrogenesis in both EC and cortex, the number of newly generated NG2 + BrdU + OPCs and APC + BrdU + oligodendrocytes was positively correlated with MBP staining intensity only in the EC and not in the cortex (Figure 4 ). This discrepancy might be related to the lack of differences in WM integrity in the cortex in db/db mice versus WT or db/+ mice after stroke, as measured by MBP staining intensities ( Figure 3 in the online-only Data Supplement) and NF200/MBP ratios ( Figure 3B ). These data are consistent with previous observations that OPCs from different CNS regions exhibit distinct temporal patterns of oligodendrocyte generation and myelinogenesis. 13 Aside from the above-mentioned observations, we also found that the impaired oligodendrogenesis in diabetic mice is partially attributed to proinflammatory microglia/macrophage responses in the ischemic diabetic brain. Microglia/ macrophage phenotype alterations exert profound influences on OPC survival, differentiation, and maturation. 6, 7 In our study, low concentration LPS-treated M1 microglia exerted minimal effects on MBP expression in OPCs within 3 days of coculturing. However, the mRNA expressions of mbp, mog, and plp genes were dramatically inhibited by LPStreated microglia, suggesting potentially lower expression of these maturation markers in OPCs at subsequent time points not assessed in the present report. Elevated glucose levels, as seen in T2DM, induce prolonged periods of microglia activation.
14 The transient surge of blood glucose during acute ischemic stroke, even in those subjects without preexisting diabetes mellitus, may drive the polarization of monocyte/macrophages toward the proinflammatory phenotype. 15 The present in vitro studies confirm a direct effect of glucose on microglial polarization. Exposure to media with high glucose levels shifted microglia under both physiological and LPS-primed conditions toward an inflammatory M1-like phenotype. This proinflammatory phenotype impaired the differentiation and maturation of OPCs, as expected. Accordingly, inflammation-prone microglia/macrophage responses in the ischemic brain of diabetic mice may obstruct oligodendrogenesis and WM repair.
Brain repair and regeneration after stroke require coordinated communication between various central and peripheral cell types. The current study focused on the impact of diabetes mellitus on microglia-OPC interactions and WM integrity. Additional evidence from the literature supports the involvement of other mechanisms in the inferior long-term outcomes in diabetic stroke mice. For example, diabetes mellitus impairs reparative neovascularization and results in a dramatic decline in the cerebrovascular network after stroke. 16 Diabetic mice exhibit diminished leptomeningeal collateral flow compensation compared with nondiabetic mice. 17 Furthermore, diabetes mellitus exacerbates blood-brain barrier damage and facilitates macrophage infiltration, which impair cognitive functions. 18 In addition, diabetes mellitus results in a significant reduction in the proliferation of doublecortin + neuroblasts and impairs dendritic/spine plasticity after stroke. 19 Whether these reparative mechanisms contribute to long-term sensorimotor or cognitive deficits in diabetic stroke victims, either independently or involving interplay with microglia/macrophages, warrants further exploration.
The point mutation in the leptin receptor lepr renders db/ db mice incapable of gauging caloric limits, resulting in high
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October 2018 blood glucose and insulin levels. Being obese and hyperglycemic, the db/db mouse is an established animal model for the obese variant of T2DM and insulin resistance. 20 However, it is important to acknowledge that db/db mice may have symptoms that are not specific to diabetic patients but are more reflective of obesity or reduced leptin function. For example, the anxiety-like behavior in the open field in db/db animals with or without ischemic injury might be related to obesity or leptin blockage as the db/+ with normal blood glucose also demonstrated a trend toward anxiety. A second limitation of the current study is that we used only young adult male mice while stroke mainly afflicts the aged population. Sex differences in ischemic injury have also been reported in diabetes mellitus mice, and estrogen might be a mechanism of brain protection in diabetic females. 21 Therefore, further studies in aged male and female diabetic mice are warranted. However, the db/db mice are not suitable for long-term studies because of their development of infectious complications with aging. In addition, although our in vivo studies were performed in a mouse model, we conducted the in vitro studies with rat OPCs because of the higher OPC yield from rat brains. Nevertheless, in agreement with our current genetic model of diabetes mellitus, recent studies using the nicotinamide-streptozotocininduced diabetic model in middle-aged rats also described impaired WM integrity and OPC differentiation after stroke in diabetic rats. 19, 22 These studies support the view that diabetes mellitus has a detrimental impact on WM repair after stroke in both rats and mice. Although the present study focused on elucidating the effects of T2DM on WM integrity after stroke, treatment strategies that target WM injury in diabetic stroke victims are not available and require further investigation. To this end, both permanent and reperfusion models of stroke should be explored as the recent clinical success of endovascular thrombectomy is expected to increase the chances of poststroke reperfusion in the near future. 23 In summary, the present study suggests that diabetes mellitus elicits deterioration in functional deficits after stroke. These functional deficits are robustly correlated with loss of WM integrity. High glucose exposure shifts microglia/macrophage polarization toward a proinflammatory phenotype, which impairs OPC differentiation. Thus, our data support the view that therapeutic modulation of microglia/macrophage polarization towards an oligodendrogenesis-enhancing phenotype may be a fruitful strategy to promote WM repair and functional recovery after stroke in diabetic patients.
